Combination therapy sustains 49% melanoma reduction after 5 years
Share on Pinterest A personalized vaccine and Keytruda combination shows durable response against melanoma over 5 years. Image credit: Luis…
Author: Team Health Accessible
When should you get a mammogram to screen for breast cancer? Experts clarify
Share on Pinterest When should you actually get a mammogram to screen for breast cancer? The Good Brigade/Getty Images The…
How prescribing prophylactic antibiotics is driving AMR
Is empiric prescribing of antibiotics as prophylaxis the biggest cause of AMR? Antimicrobial resistance (AMR) has become one of the…
Transforming biomedical research and innovation
Due for completion in 2028, the Sydney Biomedical Accelerator will be a globally significant hub for biomedical research, innovation, and…
Alzheimer’s blood test around ages 53-69 may help detect early cognitive decline
Share on Pinterest Could a midlife blood test help detect subtle and early cognitive decline? Alvaro Lavin/Stocksy Some current research…
Oslo University Hospital secures €4.9 million EU grant for older cancer patient care
Horizon Europe has granted €4.9m to Oslo University Hospital (OUS) Radiumhospitalet to lead an international research project aimed at improving…
PhotoMel investigates factors increasing melanoma risk in young adults
A major European research project led by the Medical University of Vienna will investigate how environmental factors may increase melanoma…
AI joins the quest to find new treatments for rare neuromuscular diseases
Rare neuromuscular diseases often lack treatments because developing targeted drugs is slow, costly and risky for companies. A new approach…
Justicia carnea extract alleviates oxidative stress in pancreatitis
Background and objectives Chronic pancreatitis is an inflammatory disease and is difficult to manage despite advancements in medical science. This…
Hypoxia-gated AAV enables targeted treatment for advanced NSCLC
Adeno‑associated virus (AAV) vectors offer safety and durable expression but lack tumor specificity. This hypothesis proposes an NSCLC‑directed, hypoxia‑responsive AAV…